NCT03643549 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03643549
Title	Bortezomib and Temozolomide in Recurrent Grade-4 Glioma Unmethylated MGMT Promoter (BORTEM-17) (BORTEM-17)
Acronym	BORTEM-17
Recruitment	Recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	No
Sponsors	Haukeland University Hospital
Indications	glioblastoma
Therapies	Bortezomib + Temozolomide
Age Groups:	adult \| senior
Covered Countries	NOR

Facility	Status	City	State	Zip	Country	Details
Haukeland University Hospital	RECRUITING	Bergen		5021	Norway	Details
Oslo University Hospital	RECRUITING	Oslo		0424	Norway	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT03643549Clinical Trial Detail